The prevalence of end-stage renal disease continues to risein the United States. Even more disturbingly, the current numberof patients with early chronic kidney disease — the poolfrom which future end-stage renal disease patients will emerge— exceeds the present number with end-stage renal diseaseby a factor of 30 to 60.1,2 However, early chronic kidney diseasewill not progress to end-stage renal disease in all patients.Indeed, many will probably die of other conditions first. Overthe past few years, investigators have shown that many peoplein this vast pool of patients with chronic kidney disease have. . . [Full Text of this Article]
Source Information
From the National Kidney Disease Education Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md.
This article has been cited by other articles:
Covic, A., Kothawala, P., Bernal, M., Robbins, S., Chalian, A., Goldsmith, D.
(2008). Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant
0: gfn613v1-gfn613
[Abstract][Full Text]
Cirillo, M., Lanti, M. P., Menotti, A., Laurenzi, M., Mancini, M., Zanchetti, A., De Santo, N. G.
(2008). Definition of Kidney Dysfunction as a Cardiovascular Risk Factor: Use of Urinary Albumin Excretion and Estimated Glomerular Filtration Rate. Arch Intern Med
168: 617-624
[Abstract][Full Text]
Karagiannis, S. E., Feringa, H. H.H., Elhendy, A., van Domburg, R., Chonchol, M., Vidakovic, R., Bax, J. J., Karatasakis, G., Athanasopoulos, G., Cokkinos, D. V., Poldermans, D.
(2008). Prognostic significance of renal function in patients undergoing dobutamine stress echocardiography. Nephrol Dial Transplant
23: 601-607
[Abstract][Full Text]
Authors/Task Force Members, , Bassand, J.-P., Hamm, C. W., Ardissino, D., Boersma, E., Budaj, A., Fernandez-Aviles, F., Fox, K. A.A., Hasdai, D., Ohman, E. M., Wallentin, L., Wijns, W., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Kristensen, S. D., Widimsky, P., McGregor, K., Sechtem, U., Tendera, M., Hellemans, I., Gomez, J. L. Z., Silber, S., Funck-Brentano, C., Document Reviewers, , Kristensen, S. D., Andreotti, F., Benzer, W., Bertrand, M., Betriu, A., De Caterina, R., DeSutter, J., Falk, V., Ortiz, A. F., Gitt, A., Hasin, Y., Huber, K., Kornowski, R., Lopez-Sendon, J., Morais, J., Nordrehaug, J. E., Silber, S., Steg, P. G., Thygesen, K., Tubaro, M., Turpie, A. G.G., Verheugt, F., Windecker, S.
(2007). Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J
28: 1598-1660
[Full Text]
Smith, G. L., Shlipak, M. G., Havranek, E. P., Foody, J. M., Masoudi, F. A., Rathore, S. S., Krumholz, H. M.
(2006). Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease.. Arch Intern Med
166: 1134-1142
[Abstract][Full Text]
Kimmel, P. L.
(2006). Update in nephrology and hypertension.. ANN INTERN MED
144: 281-285
[Full Text]
Schrier, R. W.
(2006). Role of Diminished Renal Function in Cardiovascular Mortality: Marker or Pathogenetic Factor?. J Am Coll Cardiol
47: 1-8
[Abstract][Full Text]
Barr, D. A.
(2005). The Practitioner's Dilemma: Can We Use a Patient's Race To Predict Genetics, Ancestry, and the Expected Outcomes of Treatment?. ANN INTERN MED
143: 809-815
[Abstract][Full Text]
Harlan, D. M., McBride, M. A.
(2005). Survival After Pancreas Transplantation--Reply. JAMA
293: 675-676
[Full Text]
Previous
